Polysaccharides, Next Potential Agent for the Treatment of Epilepsy?

Epilepsy is a chronic neurological disorder. Current pharmacological therapies for epilepsy have limited efficacy that result in refractory epilepsy (RE). Owing to the limitations of conventional therapies, it is needed to develop new anti-epileptic drugs. The beneficial effects of polysaccharides f...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xuemin, Wu, Youliang, Xie, Haitao, Wang, Haiyan, Zhang, Xiaojing, Yu, Jiabin, Zhu, Shaofang, Zhao, Jing, Sui, Lisen, Li, Shaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996301/
https://www.ncbi.nlm.nih.gov/pubmed/35418858
http://dx.doi.org/10.3389/fphar.2022.790136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996301/
https://www.ncbi.nlm.nih.gov/pubmed/35418858
http://dx.doi.org/10.3389/fphar.2022.790136

Ejemplares similares